Author

Takaaki Sasaki

Institution: Asahikawa Medical University

Observed institution: Asahikawa Medical University

ORCID: 0000-0002-6505-8786

Observed ORCID: 0000-0002-6505-8786

OpenAlex ID: A5125400441

Afatinib Versus Osimertinib for Non‐Small Cell Lung Cancer With Uncommon EGFR Mutations: Real‐World Outcomes

2026 · Yutaro Nagano, Hiroshi Yokouchi, et al. · Cancer Science · 2

Afatinib versus osimertinib for non–small cell lung cancer with uncommon epidermal growth factor receptor mutations: Real-world outcomes (HOT-Next001/HOT2501).

2026 · Yutaro Nagano, Hiroshi Yokouchi, et al. · Journal of Clinical Oncology

Comparison of anthracycline plus platinum versus other platinum-based regimens as first-line chemotherapy for untreated thymoma: A retrospective cohort study (NEJ023B)

2026 · Go Saito, Ryo Ko, et al. · Lung Cancer

Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting

2026 · Ryosuke Tsugitomi, Kento Takagi, et al. · Lung Cancer

Works count: 4

Citation count: 2

H-index: 1

I10-index: